Guangzhou Baiyunshan Pharmaceutical Holdings (874.HK) - Conservative About the Outlook
This insight analyzed Baiyunshan’s 2021Q3 performance, the core business segments, the comparison with peers, the concerns on business transition,...
484 Views
Beijing Tong Ren Tang Chinese Medicine: A Turnaround Worth A Look
Beijing Tong Ren Tang Chinese Medicine can be a rare turnaround case in our opinion, thanks to its wide moat and compounding capability.
534 Views
Shanghai/Shenzhen Connect Ideas: Moutai Inflows Were Back, Tsingtao Too (2019-06-14)
In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to help our investors understand the flow of northbound trades via the Shanghai and...
599 Views
"Donkey Skin" Rhymes With "Shark Fin" Update
Recall that E-Jiao, a Traditional Chinese Medicine made from donkey skin, is one of China Resources Pharmaceutical Group (3320 HK) 's leading...
326 Views
"Donkey Skin" Rhymes With "Shark Fin"
China Resources Pharmaceutical (3320 HK) is an integrated manufacturer, distributor, and retailer of pharmaceutical products. The company's leading...
373 Views